The Efficacy of Sentimag in Detection of Sentinel Node Biopsy
NCT02739425 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104
Last updated 2019-06-06
Summary
The aim of this study is to evaluate the Sentimag/Sienna+ System (Sentimag®) in clinical routine practice. On the one hand this allows evaluation of the equivalence of the two techniques. On the other hand this ensures that patients do not experience any possible disadvantages by participating. The hypothesis behind this evaluation is that Sentimag is as efficient as conventional sentinel node mapping.
The programme will compare the Sentimag® with the conventional sentinel lymph node detection with radioactive tracer combined with blue dye (in centres using the combined technique) and thereby determine whether the new technique is equivalent to the standard technique for SLNB.
Conditions
- Breast Cancer
- Sentinel Node
Interventions
- DEVICE
-
Sentimag Device
The programme will compare the Sentimag with the conventional sentinel lymph node detection with radioactive tracer combined with blue dye (in centres using the combined technique) and thereby determine whether the new technique is equivalent to the standard technique for SLNB
Sponsors & Collaborators
-
Sysmex Medical
collaborator OTHER -
The Royal Wolverhampton Hospitals NHS Trust
lead OTHER_GOV
Principal Investigators
-
Raghavan Vidya · The Royal Wolverhampton NHS Trust
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-22
- Primary Completion
- 2018-05-01
- Completion
- 2018-05-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Artificial Intelligence Analysis of Fluorescence Image to Intraoperatively Detect Metastatic Sentinel Lymph Node.
NCT05623280 ·Status: UNKNOWN
-
Sentinel Node Biopsy Before and/or After Neoadjuvant Chemotherapy in Breast Cancer
NCT02031042 ·Status: COMPLETED
-
Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients
NCT00952679 ·Status: UNKNOWN ·Phase: PHASE3
-
Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer
NCT02279108 ·Status: COMPLETED ·Phase: PHASE3
-
Sentinel Lymph Node Biopsy With or Without Para-Sentinel Lymph Node Dissection in Breast Cancer
NCT02651142 ·Status: UNKNOWN ·Phase: NA
-
Optimized Angiomammography and Comparison With Standard Angiomammography
NCT03155386 ·Status: COMPLETED
-
Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer
NCT01140763 ·Status: UNKNOWN
-
Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer
NCT00080860 ·Status: COMPLETED ·Phase: NA
-
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer
NCT03255577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sienna+MR Long-term Uptake
NCT03243435 ·Status: COMPLETED
-
Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy
NCT03381092 ·Status: UNKNOWN
-
Sentinel Lymph Node Biopsy in Patients With Breast Cancer After Neoadjuvant Therapy
NCT03556397 ·Status: COMPLETED ·Phase: NA
-
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
NCT06610539 ·Status: RECRUITING
-
Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients
NCT06780748 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer
NCT05615298 ·Status: COMPLETED
-
Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer
NCT07154563 ·Status: RECRUITING
-
Establishment and Clinical Application of Precise SLNB System in Breast Cancer: a Randomized, Multicenter, Controlled Study
NCT03857932 ·Status: RECRUITING ·Phase: NA
-
Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer Study
NCT00282529 ·Status: TERMINATED ·Phase: NA
-
Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer
NCT02168452 ·Status: COMPLETED
-
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC
NCT07080944 ·Status: RECRUITING ·Phase: NA
-
Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma
NCT02316795 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions
NCT02802553 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment.
NCT02249208 ·Status: UNKNOWN ·Phase: PHASE3
-
ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes
NCT01395706 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison Study of Sentinel Lymph Node Biopsy by Multimodal Method in Breast Cancer
NCT01856452 ·Status: COMPLETED ·Phase: PHASE2